Physician profile
Ryan C Mchugh
NPI 1811976715
$2,355.34
in general payments reported to CMS, 2019-2025
28 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $83.73 · 2021: $437 · 2022: $146 · 2023: $268 · 2024: $323 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $359.69 | 2019-2025 | Intracept, General - Pain Management |
| Nevro Corp. | $352.21 | 2019-2024 | Senza |
| Biotronik Nro, INC. | $323.52 | 2024-2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.71 | 2022-2025 | Relistor |
| Medtronic, INC. | $159.36 | 2023-2025 | Intellis Adaptivestim |
| Arbor Pharmaceuticals, INC. | $140.78 | 2019-2021 | |
| Inspire Medical Systems, INC. | $117.46 | 2024-2025 | Inspire |
| Epimed International, INC | $104.95 | 2021 | |
| Globus Medical, INC. | $75.28 | 2025 | Senza |
| Almatica Pharma LLC | $56.64 | 2021 | |
| Abbott Laboratories | $51.47 | 2024-2025 | Proclaim |
| Merck Sharp & Dohme LLC | $47.65 | 2021-2024 | Bridion |
| Radius Health, INC. | $40.61 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $40.14 | 2023 | Seglentis |
| Valinor Pharma, LLC | $37.13 | 2025 | Movantik |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Redhill Biopharma INC. | $32.33 | 2021 | |
| Nalu Medical, INC. | $31.36 | 2021 | |
| Abbvie INC. | $28.93 | 2022 | |
| Horizon Therapeutics Plc | $23.48 | 2020 | |
| Daiichi Sankyo INC. | $21.17 | 2019 | |
| Medtronic USA, INC. | $17.71 | 2019 | |
| Acacia Pharma INC | $16.24 | 2021 | |
| Vertos Medical, INC. | $16.00 | 2023 | Mild Device Kit |
| Si-Bone, INC. | $15.37 | 2019 | |
| Assertio Therapeutics, INC. | $13.75 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.76 | 2019 | |
| Stimwave Technologies Incorporated | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mchugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.